Cerenome, Inc. (CNSY) FinancialsCNSYCerenome, Inc.

Evaluating the bottom line, Cerenome, Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2203.65%, while the net margin is -2191.24%. These profitability ratios, combined with a Return on Equity (ROE) of -614.05%, provide a clear picture of how effectively CNSY converts its operational activities into shareholder value.

In the context of the broader market, CNSY competes directly with industry leaders such as NIKI and PULM. With a market capitalization of $4.88M, it holds a significant position in the sector. When comparing efficiency, CNSY's gross margin of 100.00% stands against NIKI's N/A and PULM's N/A. Such benchmarking helps identify whether Cerenome, Inc is trading at a premium or discount relative to its financial performance.

The company has shown erratic revenue performance with a recent total revenue of $411,000 in Q2 2026, down from $1,397,000 in Q2 2025. The gross margin remains high at 100%, but net income has been consistently negative, with a net income of -$9,006,000 in Q2 2026.